VASOMUNE

vasomune-logo

Vasomune Therapeutics is a private biotechnology company developing therapies to target diseases associated with blood vessel (vascular) dysfunction and destabilization. The inner most layer of blood vessels is made up of individual endothelial cells that regulate the passage of immune and inflammatory cells to a site of injury. In many different disease states, dysfunctional vasculature results in an exaggerated inflammatory response. Vascular dysfunction can lead to, or exacerbate many differe... nt diseases such as cardiovascular, renal, pulmonary and oncology. The companyโ€™s lead compound is Vasculotide, a Tie2 receptor agonist that has demonstrated positive therapeutic effect in many different diseases associated with vascular dysfunction. Vasomune Therapeutics, spun out of MaRS Innovation, Sunnybrook Hospital and Health Sciences Centre at the University of Toronto in 2012, is translating a strong foundation of academic science into clinical practice. Vasomuneโ€™s initial programs focus on targeting acute and chronic diseases of the kidney. The lead development program takes aim at treating Acute Kidney Injury (AKI), a significant unmet medical need. While several distinct clinical paths exist for the development of Vasculotide, the decision to pursue AKI is based on a strong, third-party validated preclinical data set and converging evidence that vascular dysfunction lies at the core of AKI.

#SimilarOrganizations #People #Financial #Website #More

VASOMUNE

Industry:
Biotechnology Health Care Life Science Therapeutics

Founded:
2012-01-01

Address:
Toronto, Ontario, Canada

Country:
Canada

Website Url:
http://www.vasomune.com

Total Employee:
11+

Status:
Active

Total Funding:
13.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system


Current Advisors List

rafi-hofstein_image

Rafi Hofstein Member of the Board of Directors @ Vasomune
Board_member

Current Employees Featured

parimal-nathwani_image

Parimal Nathwani
Parimal Nathwani President & CEO @ Vasomune
President & CEO
2012-01-01

douglas-a-hamilton_image

Douglas A. Hamilton
Douglas A. Hamilton President and Chief Executive Officer @ Vasomune
President and Chief Executive Officer
2018-10-01

Investors List

u-s-department-of-defense_image

U.S. Department of Defense

U.S. Department of Defense investment in Grant - Vasomune

national-research-council-of-canada-industrial-research-assistance-program_image

National Research Council of Canada Industrial Research Assistance Program

National Research Council of Canada Industrial Research Assistance Program investment in Grant - Vasomune

u-s-department-of-defense_image

U.S. Department of Defense

U.S. Department of Defense investment in Grant - Vasomune

genome-canada_image

Genome Canada

Genome Canada investment in Seed Round - Vasomune

mars-innovation-mi_image

Toronto Innovation Acceleration Partners

Toronto Innovation Acceleration Partners investment in Pre Seed Round - Vasomune

sunnybrook-research-institute_image

Sunnybrook Research Institute

Sunnybrook Research Institute investment in Pre Seed Round - Vasomune

Official Site Inspections

http://www.vasomune.com Semrush global rank: 5.92 M Semrush visits lastest month: 1.39 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Vasomune" on Search Engine